Q4 2025 Management View CEO Christopher Caldwell highlighted that "for the past few years, we have been clear about evolving ...
Achieved 98% manufacturing batch success rate at BaseCamp across cell therapy, viral vector, and mRNA– Positioned U.S.-based biomanufacturing ...
CEO Matthew Bromberg highlighted that "Unity showed strength across both our Grow and Create segments, driving results that once again meaningfully exceeded both our guidance and consensus for both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results